BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37145265)

  • 1. TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer.
    Tong X; Liu YS; Tong R; Tang WW; Li XM; Wang CY; Wang YP
    Hum Cell; 2023 Jul; 36(4):1535-1547. PubMed ID: 37145265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
    He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
    Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
    Wang YQ; Wu DH; Wei D; Shen JY; Huang ZW; Liang XY; Cho WCS; Ma J; Lv J; Chen YP
    Sci Adv; 2023 Jan; 9(1):eadd0960. PubMed ID: 36608137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
    Li N; Li D; Du Y; Su C; Yang C; Lin C; Li X; Hu G
    Oncol Rep; 2019 Feb; 41(2):875-884. PubMed ID: 30535429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
    Wu L; Zhao N; Zhou Z; Chen J; Han S; Zhang X; Bao H; Yuan W; Shu X
    Theranostics; 2021; 11(2):700-714. PubMed ID: 33391500
    [No Abstract]   [Full Text] [Related]  

  • 6. TEAD4 overexpression suppresses thyroid cancer progression and metastasis
    Zhang B; Wang Q; Ji Y; Zhang X; Xue L; Shi Q; Li J
    J Biosci; 2022; 47():. PubMed ID: 34951409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
    Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
    EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
    Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.
    Hu W; Zheng S; Guo H; Dai B; Ni J; Shi Y; Bian H; Li L; Shen Y; Wu M; Tian Z; Liu G; Hossain MA; Yang H; Wang D; Zhang Q; Yu J; Birnbaumer L; Feng J; Yu D; Yang Y
    Hepatology; 2021 Feb; 73(2):674-691. PubMed ID: 32335942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.
    Zhang Q; Fan H; Zou Q; Liu H; Wan B; Zhu S; Hu Y; Li H; Zhang C; Zhou L; Zhu Q; Xiao K; Zhang J; Zhan P; Lv T; Song Y
    J Cell Mol Med; 2018 Jul; 22(7):3560-3571. PubMed ID: 29667772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
    Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
    J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer.
    Xu B; Zhang X; Wang S; Shi B
    Pathol Res Pract; 2018 May; 214(5):790-795. PubMed ID: 29653747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer.
    Li Q; Tong D; Jing X; Ma P; Li F; Jiang Q; Zhang J; Wen H; Cui M; Huang C; Zhang M
    Cancer Gene Ther; 2023 May; 30(5):727-737. PubMed ID: 36599972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1.
    Wu L; Zhou Z; Han S; Chen J; Liu Z; Zhang X; Yuan W; Ji J; Shu X
    Br J Cancer; 2020 Feb; 122(4):578-589. PubMed ID: 31827238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
    Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
    Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1.
    Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY
    Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
    Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
    Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Silencing of Transcription Factor
    He S; Gao K; Mao L; Bhushan S; Xiao Z
    Cancer Biother Radiopharm; 2023 Mar; 38(2):132-139. PubMed ID: 32822226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.